Latest News about Briefs
Recent news which mentions Briefs
London's Heathrow, Collins Aerospace Ink Long-Term Deal To Enhance Airport Operations
April 09, 2025
From Benzinga
Why Lumen Technologies Stock Is Up On Wednesday
April 09, 2025
From Benzinga
Why Is EV Maker Mullen Automotive Stock Tanking Today?
April 09, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
FDA Approves Bristol Myers' Opdivo Plus Yervoy Combo For Untreated Colorectal Cancer Patients
April 09, 2025
From Benzinga
Affirm And Shopify Expand 'Buy Now, Pay Later' To Canada And UK In Global Growth Push
April 09, 2025
From Benzinga
From Benzinga
Nokia, Telia Break Ground With Live 5G Slice Trial Across Three Nations For Defense Operations
April 09, 2025
From Benzinga
Taiwan Semi Could Face More Than $1 Billion In US Penalty Over Alleged Huawei Chip Link: Reuters
April 09, 2025
From Benzinga
Walmart Maintains Steady Growth Forecast Despite Tariffs
April 09, 2025
From Benzinga
What's Going On With Interactive Strength Stock Today?
April 09, 2025
From Benzinga
Delta Air Lines Wants To Protect Margins And Cash Flow Citing Economic Uncertainty, Does Not Reaffirm FY25 Outlook
April 09, 2025
From Benzinga
From Benzinga
Neogen Q3 Earnings Fall Short On Expectations, Cuts Guidance Amid Macro Headwinds And Tariff Concerns
April 09, 2025
From Benzinga
Foxconn Eyes Nissan, Mitsubishi In Japan EV Push To Counter China's Growing Auto Threat
April 09, 2025
From Benzinga
Why Is Simply Good Foods Stock Gaining Today?
April 09, 2025
From Benzinga
EXCLUSIVE: Capstone Eyes $100 Million Goal With Southeast Expansion, Targets 1,500 Acquisition Opportunities
April 09, 2025
From Benzinga
EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent
April 09, 2025
From Benzinga
China Markets Up, Europe Tumbles As Trade War Escalates; Oil Hits Multi-Year Low - Global Markets Today While US Slept
April 09, 2025
From Benzinga
From Benzinga
Cell Therapy Maker Legend Biotech Is An 'Attractive Opportunity' Due To No Material Tariff Exposure: Analyst
April 08, 2025
From Benzinga
From Benzinga
From Benzinga
Johnson & Johnson's New 'Compelling Data' Shows Sustained Symptom Improvement In Muscular Disease Patients
April 08, 2025
From Benzinga
Cartesian Therapeutics Reports Strong 12-Month Data For Lead Cell Therapy In Myasthenia Gravis Patients
April 08, 2025
From Benzinga
Argenx's Flagship Drug Vyvgart Shows Sustained Disease Control In Rare Neuromuscular Disease Patients
April 08, 2025
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.